Clinical Trials for Prostate Cancer Metastatic

Find clinical trials for prostate cancer metastatic. Discover research opportunities and treatment options in your area.

31 Active Trials Found

Showing 31 trials on this page

Page 1 of 2

Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

NCT ID: NCT06136624

This clinical trial is studying a new medication called opevesostat (MK-5684) to see how well it works compared to two other treatments, abiraterone acetate and enzalutamide, in patients with metas...

Recruiting

Phase: PHASE3 Type: interventional Locations: Suita, Osaka, Japan, Quebec City, Quebec, Canada +335 more

Geriatric Assessment and Technology Evaluation in Prostate Cancer

NCT ID: NCT06215508

This clinical trial is looking to understand how certain factors contribute to frailty and serious side effects in older men (65 years and older) who have prostate cancer that has spread to other p...

Recruiting

Type: observational Locations: Chicago, Illinois, United States

Castrate Resistant Prostate Cancer Enhertu Therapy

NCT ID: NCT06610825

This clinical trial is studying a treatment called Enhertu for men with a specific type of prostate cancer known as metastatic castration-resistant prostate adenocarcinoma (mCRPC) that tests positi...

Recruiting

Phase: PHASE2 Type: interventional Locations: Washington Dc, District Of Columbia, United States

Exercise in Prostate Cancer

NCT ID: NCT06165302

This clinical trial, titled "Exercise in Prostate Cancer," is designed to explore how exercise can impact the number of circulating tumor cells (CTCs) in men with advanced prostate cancer. The main...

Not yet recruiting

Phase: NA Type: interventional

Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617

NCT ID: NCT06972628

This clinical trial is studying a treatment called Lutetium-177-PSMA-617, or Pluvicto, for men with metastatic castration-resistant prostate cancer (mCRPC) who have extensive bone metastases, speci...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

Ablative Radiotherapy to Consolidate Maximal Systemic Response in Metastatic Prostate Cancer (ANCHOR-Prostate)

NCT ID: NCT05457699

The ANCHOR-Prostate trial is studying a new treatment approach for men with metastatic prostate cancer, which is cancer that has spread beyond the prostate. Specifically, the trial is looking at a ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Montreal, Quebec, Canada

Dutch National Randomized Study: PSMA-PET/CT As a Triage Tool for Pelvic Lymph Node Dissection in Prostatectomy Patients

NCT ID: NCT05000827

This clinical trial is exploring a new way to help doctors decide if a specific surgical procedure called extended lymph node dissection (ePLND) is necessary for men with prostate cancer. The study...

Recruiting

Phase: NA Type: interventional Locations: Nijmegen, Gelderland, Netherlands

Clinical Application of the J-PET Scanner Prototype

NCT ID: NCT06242119

This clinical trial is exploring a new type of imaging technology called the J-PET scanner, which is designed to help doctors better diagnose certain conditions like prostate cancer and other relat...

Recruiting

Type: observational Locations: Krakow, , Poland

Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer

NCT ID: NCT03833921

This clinical trial is studying how different factors, including race and ethnicity, may affect the response to standard treatments for metastatic hormone-naive prostate cancer. The treatments bein...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States, Houston, Texas, United States +1 more

FTT PET/CT in Metastatic Prostate Cancer

NCT ID: NCT05242744

This clinical trial is looking at a special type of imaging called FTT PET/CT scans to help doctors understand how well a new treatment for metastatic prostate cancer is working. Up to 30 men who h...

Recruiting

Type: observational Locations: Philadelphia, Pennsylvania, United States

Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer

NCT ID: NCT06171139

This clinical trial is focused on improving the way Black or African American men with metastatic prostate cancer receive counseling about tumor genetic testing. The goal is to ensure that these pa...

Recruiting

Phase: NA Type: interventional Locations: San Francisco, California, United States

Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy

NCT ID: NCT05327465

This clinical trial is exploring whether a special 16-week exercise program can help improve heart health in Black men with prostate cancer who are receiving a treatment called androgen deprivation...

Recruiting

Phase: NA Type: interventional Locations: Boston, Massachusetts, United States

Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders)

NCT ID: NCT06496581

The PEACE-6 Poor Responders trial is a study looking at how well a treatment called 177Lu-PSMA-617 works for men with a type of prostate cancer that has spread and is sensitive to hormone therapy. ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Paris, , France, Bordeaux, , France +23 more

Metastasis Directed Stereotactic Body Radiotherapy for Oligo Metastatic Hormone Sensitive Prostate Cancer

NCT ID: NCT04983095

This clinical trial is studying a type of radiation therapy called Metastasis Directed Stereotactic Body Radiotherapy (MD-SBRT) for men with hormone-sensitive prostate cancer that has spread to a f...

Recruiting

Phase: NA Type: interventional Locations: Stockholm, , Sweden, Stockholm, Region Stockholm, Sweden +8 more

ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials

NCT ID: NCT06141993

The ARCTIC clinical trial is studying men with advanced prostate cancer that has not responded to standard hormone treatments. Researchers want to find out if certain genes or proteins found in the...

Recruiting

Type: observational Locations: Durham, North Carolina, United States, New York, New York, United States +1 more

The Diagnostic Value of FAPI PET/CT in Staging of Newly Diagnosed Prostate Cancer

NCT ID: NCT06634173

This clinical trial is looking into a new imaging technique called FAPI PET/CT to see how well it can stage newly diagnosed prostate cancer compared to the standard method, PSMA PET/CT. The goal is...

Not yet recruiting

Phase: NA Type: interventional

ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)

NCT ID: NCT04916613

The PEACE6-Vulnerable trial is studying the effects of a treatment called androgen deprivation therapy (ADT) with or without darolutamide in men with newly diagnosed metastatic prostate cancer. Thi...

Recruiting

Phase: PHASE3 Type: interventional Locations: Nice, , France, Clermont Ferrand, , France +91 more

A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer

NCT ID: NCT06320067

The STAMPEDE2 trial is a research study aimed at finding out how well three new treatments work for men with prostate cancer that has spread to other parts of the body and can respond to hormone th...

Recruiting

Phase: PHASE3 Type: interventional Locations: London, , United Kingdom, Sutton, , United Kingdom +2 more

Metastasis-directed Therapy for Oligorecurrent Prostate Cancer

NCT ID: NCT05352178

This clinical trial is studying a new treatment approach for men with a specific type of prostate cancer called oligorecurrent hormone-sensitive prostate cancer. The researchers want to see if addi...

Recruiting

Phase: PHASE3 Type: interventional Locations: Leuven, , Belgium

Pembrolizumab, Carboplatin and Cabazitaxel in Aggressive Metastatic Castration Resistant Prostate Cancer (PEAPOD_FOS)

NCT ID: NCT05563558

The PEAPOD_FOS clinical trial is studying a combination of three medications—Pembrolizumab, Carboplatin, and Cabazitaxel—to see how effective they are in treating aggressive metastatic castration-r...

Recruiting

Phase: PHASE2 Type: interventional Locations: Madrid, , Spain

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions